Hostname: page-component-7f64f4797f-m2b9p Total loading time: 0 Render date: 2025-11-06T11:06:19.319Z Has data issue: false hasContentIssue false
  • English
  • Français

The Use of Mupirocin in Controlling Methicillin-Resistant Staphylococcus aureus

Published online by Cambridge University Press:  21 June 2016

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 1 , January 1990 , pp. 11 - 12
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990 

References

1. Malouin, F., Bryan, LE. Modification of penicillin-binding proteins as mechanisms of resistance to beta-lactam antibiotics. Antimicrob Agents Chemother. 1986; 30:1–5.Google Scholar
2. McDougal, LK, Thornsbery, C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Mcrobiol. 1986; 23:832–839.Google Scholar
3. Morrison, AJ, Wenzel, Rl? Nosocomial urinary tract infections due to enterococcus. Arch Intern Med. 1986; 146:1549–1551.Google Scholar
4. Jervons, MP. ‘Celbenin’-resistant staphylococci. Brit Med J. 1961; 1:124–125.Google Scholar
5. Haley, RW, Hightower, AN, Khabbaz, RF, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in the United States hospitals. Ann Intern Med. 1982; 97:297–308.Google Scholar
6. Thomas, JC, Bridge, J, Waterman, S, Vogt, J, Kilman, L, Hancock, G. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol. 1989; 10:106–110.Google Scholar
7. Neu, HC: Overview of mechanisms of bacterial resistance. Diagn Microbiol InfectDis. 1989; 12(Suppl):109–116.Google Scholar
8. Casewell, MW, Hill, RLR. In vitro activity of mupirocin (pseudomonic acid) against clinical isolates of Staphylococcus aureus. J. Antimicrob Chemother. 1985; 15:523–531.Google Scholar
9. Casewell, MW, Hill, RLR. Mupirocin (pseudomonic acid)—a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987; 19:1–5.Google Scholar
10. Hosoital Infection Society and British Society for Antimicrobial Chemotherapy. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1986; 7:193–201.Google Scholar
11. Rahman, M, Nobel, WC, Cookson, B. Mupirocin-resistant Staphylococcus aureus. Lancet. 1987;2:387.Google Scholar
12. Smith, GE, Kennedy, CT. Staphylococcus aureus resistant to mupirocin. J Antimicrob Chemother. 1988;21:141–142.Google Scholar
13. Bitar, CM, Mayhall, CG, Lamb, VA, Bradshaw, TJ, Spadora, AC, Dalton, HF? Outbreak due to methicillin and rifampin resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital. Intfect Control. 1987;8:15–23.Google Scholar